14 July 2026 : Original article
iTRAQ- and MRM-Based Proteomics Identify Early Injury Biomarkers for Primary Dysfunction After Liver Transplantation
Xiaohong Lin ABCE 1,2, Wanzhen Cai ABCE 3, Xitao Hong ABCE 1, Ziming Ye BC 3, Yuqi Dong
BC 1, Shuai Wang CD 1, Xiaoshun He ADFG 1, Donghong Li CDE 4, Weiqiang Ju ADG 1*, Maogen Chen ADEFG 1
DOI: 10.12659/AOT.952366
Ann Transplant 2026; 31:e952366
Figure 7 Verification of target proteins using MRM assay. (A) The different normalized peptide intensity detected by MRM assay, n=5, ** FDR <0.01, *** FDR <0.001, FDR <0.05 means a significant difference. (B) Heat map showing the change in abundance of differentially expressed proteins in PNF2 vs Control group, as measured using iTRAQ (left panel) and MRM (right panel).